Precision Biosciences Inc (DTIL)

04:10 AM

What institutional investors are buying Precision BioSciences Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

04:10 AM

01:28 AM

What catalysts could drive Precision BioSciences Inc. stock higher in 2025Financial News Forecasts For Smart Trading - jammulinksnews.com

01:28 AM

08:01 AM

What are analysts’ price targets for Precision BioSciences Inc. in the next 12 monthsInvest confidently with proven investment plans - jammulinksnews.com

08:01 AM

05:05 AM

What are Precision BioSciences Inc. company’s key revenue driversBuild wealth steadily with expert advice - jammulinksnews.com

05:05 AM

Jul 27, 2025

What are the technical indicators suggesting about Precision BioSciences Inc.Explosive capital appreciation - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What is Precision BioSciences Inc. company’s growth strategyDiscover dynamic stocks ready to soar - jammulinksnews.com

Jul 27, 2025

Jul 26, 2025

Why Precision BioSciences Inc. stock attracts strong analyst attentionConsistent Win Signals - Metal.it

Jul 26, 2025

Jul 25, 2025

What drives Precision BioSciences Inc. stock priceDynamic investment opportunities - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

What analysts say about Precision BioSciences Inc. stockOver 200% growth - Autocar Professional

Jul 24, 2025

Jul 23, 2025

Precision BioSciences shares climb after FDA grants orphan drug status - MSN

Jul 23, 2025

Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD - Contract Pharma

Jul 23, 2025

Jul 23, 2025

Precision Biosciences’ PBGENE-DMD gains US orphan drug designation - BioWorld MedTech

Jul 23, 2025

Jul 23, 2025

Precision BioSciences stock rises after FDA grants orphan drug status By Investing.com - Investing.com Canada

Jul 23, 2025

Jul 23, 2025

FDA Grants Orphan Drug Designation to Precision BioSciences' PBG - GuruFocus

Jul 23, 2025

Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment - Investing.com Australia

Jul 23, 2025

Jul 23, 2025

FDA grants orphan drug status to Precision BioSciences’ DMD treatment By Investing.com - Investing.com South Africa

Jul 23, 2025

Jul 23, 2025

Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Jul 23, 2025

Jul 22, 2025

Precision BioSciences Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Precision BioSciences Secures Orphan Drug Designation for DMD Treatment, DTIL Stock News - AInvest

Jul 19, 2025

Jul 17, 2025

Precision BioSciences Duchenne muscular dystrophy treatment gets orphan status - TipRanks

Jul 17, 2025

Jul 17, 2025

Precision BioSciences gets FDA orphan drug designations for DMD treatment By Investing.com - Investing.com Canada

Jul 17, 2025

Jul 16, 2025

Precision BioSciences reports promising DMD gene editing results By Investing.com - Investing.com Canada

Jul 16, 2025

Jul 16, 2025

Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire

Jul 16, 2025

Jul 16, 2025

How Precision BioSciences Inc. stock performs during market volatilityFree Market Sentiment Analysis - Newser

Jul 16, 2025

Jul 15, 2025

Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN

Jul 15, 2025

Jul 15, 2025

What makes Precision BioSciences Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025

Jul 12, 2025

(DTIL) Proactive Strategies - news.stocktradersdaily.com

Jul 12, 2025

Jul 08, 2025

Precision Biosciences CFO Sells Shares to Cover Tax Obligations - TradingView

Jul 08, 2025

Jun 30, 2025

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025